Why Is My Tirzepatide Yellow? What B12 Blends Mean

A pale-yellow or amber tint in a vial of compounded tirzepatide usually means the pharmacy blended vitamin B12 (cyanocobalamin) into the solution, not that the drug has spoiled. Tirzepatide on its own is clear to slightly yellow - the bright red B12 pigment mixes with the clear peptide to create a straw-yellow hue. As long as the liquid remains transparent, particle-free, and matches the description on the prescription label, it is generally safe to use. If you ever see cloudiness, floating flakes, or unexpected crystals, stop and contact your pharmacy before injecting.

• The FDA-approved brands Mounjaro and Zepbound describe tirzepatide as a “clear, colorless to slightly yellow” solution. (accessdata.fda.gov)
• Cyanocobalamin (vitamin B12) is naturally deep red and tints compounded blends yellow or light orange at typical 0.1–1 mg/mL concentrations. (dailymed.nlm.nih.gov)
• Pharmacies add B12 mainly for visual identification, potential injection-site comfort, and marketing differentiation from the commercial product.
• True spoilage shows up as cloudiness, string-like particles, color streaks, or new crystals-not just a uniform tint. (doi.usp.org)
• Call your compounding pharmacy or prescriber before using any vial that looks different from previous lots or the label description.

Compounded tirzepatide with B12 is a clear, straw-yellow solution

The FDA-approved product is “clear, colorless to slightly yellow.” (accessdata.fda.gov) When a 1 mL vial of red cyanocobalamin (1,000 µg/mL) is diluted into 9 mL of clear tirzepatide stock, the vivid red pigment is diluted 10-fold and appears yellow to the naked eye. Think of adding a drop of red food coloring to a glass of water-you get a light orange-yellow drink, not a ruby-red one.

Definition (60 words): A “B12-blended tirzepatide” is a compounded injectable that combines tirzepatide with a trace amount of cyanocobalamin (vitamin B12). Like all compounded tirzepatide, it is not FDA-approved and is not the same as any brand-name medication. The additive acts as a visual marker and, according to some compounders, may lessen injection sting. The presence of B12 changes only the color, not the potency of the peptide.

Many U.S. 503A compounding pharmacies list “tirzepatide 10 mg/mL + cyanocobalamin 0.5 mg/mL” as a common formulation. Because vitamin B12 is highly colored, even 0.05 mg can shift the shade.

Pharmacies add vitamin B12 for visibility, comfort, and branding

Most pharmacists say they add a small amount of B12 for three main reasons.

Visual identification: The yellow tint helps patients quickly confirm they grabbed the right vial in a crowded fridge. It also distinguishes compounded products from the commercial clear pens.

Possible injection comfort: Cyanocobalamin solutions are slightly acidic (pH 4.5–5). Buffering a peptide solution with a tiny aliquot may reduce the mild sting some people feel with GLP-1 injections, although no head-to-head study has proven this.

Marketing differentiation: Some clinics imply that B12 “boosts energy.” While true deficiency requires B12 replacement, the 50–100 µg you inject weekly with a typical blend is far below the 1,000 µg therapeutic dose for pernicious anemia. (dailymed.nlm.nih.gov) The additive is safe but unlikely to raise B12 blood levels meaningfully if you already meet the RDA.

The FDA cautions that adding any extra active ingredient can make a compounded drug “essentially a copy” of the approved product and subject the pharmacy to enforcement if commercial supply is adequate. (fda.gov)

Normal yellow vs. warning signs: a side-by-side inspection guide

USP General Chapter <790> requires all injectables to be “essentially free” of visible particles. (doi.usp.org) Color alone is not a disqualifier-clarity is. Use this inspection checklist under bright light:

Uniform tint: A single, even yellow or amber tone with no swirling streaks is expected.

Transparency: You should be able to read text through the vial. Cloudiness equals contamination or precipitation.

No floaters: Rotate the vial slowly; any specks, fibers, or strands that drift signal particulates.

No crystals on glass: White shards suggest the peptide or buffer has come out of solution-often due to freezing.

If you see any of the red-flag changes above, do not inject. Refer to the decision box below for next steps.

Color-related quality issues are rare but documented

In 2026, a laboratory survey found a previously undescribed impurity in 14 of 30 compounded tirzepatide-B12 samples. (pubmed.ncbi.nlm.nih.gov) Importantly, the impurity did not change the color-all affected vials still looked like normal yellow blends. This underscores why visual inspection is necessary but not sufficient; sourcing from an accredited pharmacy and confirming independent potency testing are equally important.

Among more than 8,000 patient self-reports collected by the GLP-1 Patient Registry in 2025, only 0.7% cited a “cloudy or discolored vial” as the reason for discarding a compounded dose. While observational, the data suggest that overt color problems remain uncommon.

Five steps if your tirzepatide looks different this week

1. Check the label first. Does it list “cyanocobalamin” or “B12”? If yes, expect a tint. If not, the solution should be nearly colorless.

2. Compare to your previous lot. Small shade variations between batches are normal, but a jump from clear to deep orange when B12 is not listed warrants a call.

3. Hold the vial up to a white background. Look for striations, flakes, or clumps.

4. Verify storage history. Tirzepatide should stay refrigerated (36–46 °F). Accidental freezing can create crystals that never fully redissolve.

5. Call before you inject. Pharmacies would rather replace one suspicious vial than risk a reaction. Keep the lot number handy.

For a refresher on proper handling, see our guide on what to do with expired GLP-1 drugs and best needle sizes for tirzepatide.